Gene therapy: a viable therapeutic strategy for Parkinson's disease? - Wikidata - awgldk - TriplyDB

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

http://www.wikidata.org/entity/Q37801855

about

The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders.Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.Critical aspects of clinical trial design for novel cell and gene therapies.Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders.Gene-based therapies in Parkinson's disease.Antioxidant gene therapy against neuronal cell death.Milestones in Parkinson's disease therapeutics.Parkinson's disease: an update on pathogenesis and treatment.The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.From optogenetic technologies to neuromodulation therapies.

P2860

Q27023715-DFE9C8B3-B178-4AE0-B824-D21CB66FEF04 Q33807060-5024B184-F990-4F75-8CD7-38D0037F24E4 Q34897526-DDC35109-6BF7-41A1-AD44-A3972010DC70 Q35054395-076FB30B-9DCA-4C1F-B567-A38489B57F91 Q35664438-E709C959-5635-4627-9DC6-6FBFE9EAAAFE Q35910290-374629FE-A67F-4441-A3DC-F39D92022E19 Q37506503-E146EC4C-D631-4211-BCF8-D462440A0941 Q37647941-2F60B487-5C0E-4364-9E53-6A3ADECD7E71 Q37882596-2BD3FF86-71F8-4362-BB05-8D28938CE7F6 Q38099279-D03EEC57-AB9E-4F08-B3AB-CB9361DE069E Q41467663-D8A06ABC-D8C5-417D-B972-031ABA8B88F3 Q46083455-87D00DDA-C1F2-4097-B935-7413B1D6BC92

P2860

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

http://www.wikidata.org/entity/Q37801855

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

@en

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

@nl

type

label

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

@en

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

@nl

prefLabel

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

@en

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

@nl

P1433

Q37801855-E539F7BF-D148-496F-8A25-57E150EF3A99

P1476

Q37801855-DCF5B9FD-694D-4D48-81C6-7F67F149CBB9

P2093

Q37801855-012FC3BF-2A82-4C5F-A323-50C9001D96E1

P2860

Q37801855-00618B9A-03A7-4333-BFF2-BCDA1BEDBC62

Q37801855-1146EBFA-08D8-4D8F-AA64-80C745D29C99

Q37801855-16CA7610-0A88-4679-BE65-4FA199B60B1E

Q37801855-18DE0709-5B06-4C6B-B2AC-4F506515C4F6

Q37801855-19BB8256-D653-4D48-9704-A6F2F82308D4

Q37801855-1D58B9DF-3323-486D-A76E-F71842D6F521

Q37801855-200A45D0-363C-49C7-8344-B7FF3D303FEA

Q37801855-27AE43E1-728B-49F6-9970-244388F12714

Q37801855-2955AC55-148F-470C-8571-07E0B9BE925A

Q37801855-29DA20C4-A629-45FC-A8D8-9208A80A36FE

P2888

Q37801855-324E22BE-AA0C-4E3B-AF8E-72936547AD6A

P304

Q37801855-8693693C-6DFF-4A14-B7DA-DF0C32E7CE1E

P31

Q37801855-699CCA1D-824C-4E51-B853-078042713D72

P356

Q37801855-10DFCB1D-1DCD-4A73-A1DC-A4657D3E8979

P433

Q37801855-17EB4FB6-D96A-4602-BFA5-057EDEBE3126

P478

Q37801855-E2A7D366-B1CC-462B-9EEB-7A88B0B5FC4F

P50

Q37801855-7A1FC830-3282-468C-AE37-25C0A8C5576C

P577

Q37801855-49A84CDE-3D49-45D0-8F0A-B1C9C9325F8E

P698

Q37801855-322C45E9-0B15-475D-A52E-43605859B5BB

P921

Q37801855-326B8440-38D7-4486-9D5F-580E6308469B

Q37801855-443F4927-8CF3-4E58-BA69-CAAEE7067612

P356

S00415-010-5796-9

P1433

Journal of Neurology

P1476

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

@en

P2093

Alexander L Berry

http://www.w3.org/2001/XMLSchema#string

P2860

Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

Functional recovery in parkinsonian monkeys treated with GDNF

Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

Staging of brain pathology related to sporadic Parkinson's disease

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons

AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

P2888

s00415-010-5796-9

P304

179-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-010-5796-9

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

258

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Foltynie

P577

2010-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20963433

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease